The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Expands robotics to 20+ specialities
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
The facility has been set up to manufacture tuberculosis testing cartridges
Proposed combination enhances Pfizer’s position as a leading company in oncology
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Subscribe To Our Newsletter & Stay Updated
